SPONSOR

China National Center for Cardiovascular Diseases

Total Trials

Recruiting

Phases

Phase 4

Conditions studied: Cardiogenic Shock Heart Failure CABG-patients CABG Cardiovascular Surgery Surgeons Artificial Intelligence (AI)Atherosclerotic Heart Disease Type 2 Diabetes Percutaneous Coronary Intervention

China National Center for Cardiovascular Diseases is a clinical research sponsor with 15 registered studies on ClinicalTrials.gov, of which 15 are actively recruiting participants. Research covers conditions including Cardiogenic Shock, Heart Failure, CABG-patients, CABG.

The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — China National Center for Cardiovascular Diseases

How many clinical trials has China National Center for Cardiovascular Diseases sponsored?

ClinicalMetric currently tracks 15 clinical trials sponsored by China National Center for Cardiovascular Diseases, of which 15 are actively recruiting participants. These trials cover conditions including Cardiogenic Shock, Heart Failure, CABG-patients. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does China National Center for Cardiovascular Diseases research focus on?

China National Center for Cardiovascular Diseases clinical trials span Cardiogenic Shock, Heart Failure, CABG-patients, CABG, Cardiovascular Surgery, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a China National Center for Cardiovascular Diseases clinical trial?

To participate in a China National Center for Cardiovascular Diseases trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all China National Center for Cardiovascular Diseases trials with current recruitment status updated daily.

China National Center for Cardiovascular Diseases

Frequently Asked Questions — China National Center for Cardiovascular Diseases

Clinical Trials by China National Center for Cardiovascular Diseases

Safety and Efficacy of the Extracorporeal Ventricular Assist System in Car Diogenic Shock: A Prospective, Multicenter , Single-Arm Study

Corheart 6: Long-term Cohort Study

AI Model for Assessing Cardiac Surgeons' Techniques

Metformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease

IVUS-FFR Accuracy for Coronary Stenosis

The Chinese Hypertrophic Cardiomyopathy Study(CHCS)

Perioperative Transcutaneous Fluorescence Detection of GFR Trajectory for the Early Prediction and Diagnosis of CSA-AKI.

The FAVOR V AMI Trial

A Prospective Multicenter Real-World Registry of Quantitative Flow Ratio-Guided Coronary REvascularization and QuAlity evaLuation

Potts-shunt for the Treatment of Pediatric Patients With Severe Pulmonary Hypertension

Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation

"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients

National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis

Clinical Implications of Three-vessel Ultrasonic Flow Ratio Measurement in Patients With Coronary Artery Disease

Non-pharmacologial, Non-invassive Intervention Before Cardiac Surgery: a Randomized Controlled Trial